Hepatitis C virus (HCV) core protein assay in chronic hemodialysis patients.
نویسندگان
چکیده
منابع مشابه
Hepatitis C virus (HCV) core serotypes in chronic HCV infection.
Recently, two distinct hepatitis C virus (HCV) serologic types have been identified on the basis of amino acid variations in the core region. The two serologic types can readily discriminate between genotypes I-II-V (serotype 1) and III-IV (serotype 2), according to the Okamoto classification. We compared HCV core serotyping with genotyping with sera from 363 anti-HCV-positive patients (309 HCV...
متن کاملHepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
Background: To evaluate the prevalence of hepatitis C by antibody testing, HCV-RNA detection by PCR and relative risk factors of HCV infection among HD patients and staff members in Markazi Province/Iran. The other purpose was to determine genotypes of HCV in this population. Methods: The study group consisted of 204 HD patients and 47 staff members from all 9 dialysis centers in Markazi Provin...
متن کاملClinical usefulness of HCV core antigen assay for the management of patients with chronic hepatitis C.
AIM The study aimed to evaluate the clinical utility of the chemiluminescent HCV core Ag test compared to viral load assessment in the management of patients with chronic hepatitis C. METHODS A retrospective study was performed at a tertiary-care infectious diseases hospital on samples collected from anti-HCV positive patients. Seventy-six samples were tested with the Architect HCV core Antig...
متن کاملhepatitis c virus infection and hcv genotypes of hemodialysis patients
background: to evaluate the prevalence of hepatitis c by antibody testing, hcv-rna detection by pcr and relative risk factors of hcv infection among hd patients and staff members in markazi province/iran. the other purpose was to determine genotypes of hcv in this population. methods: the study group consisted of 204 hd patients and 47 staff members from all 9 dialysis centers in markazi prov...
متن کاملNovel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients.
Dialysis patients remain a high-risk group for hepatitis C virus (HCV) infection. The current diagnosis of HCV infection among dialysis patients includes serological assays and nucleic acid amplification technology (NAT) for assessing serum anti-HCV antibody and HCV viremia, respectively. However, current NAT techniques are expensive and labor-intensive and often lack standardization. An assay ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Toseki Igakkai Zasshi
سال: 2001
ISSN: 1883-082X,1340-3451
DOI: 10.4009/jsdt.34.1181